National Academy of Medicine

Global Health Risk Framework

The Neglected Dimension of Global Security: A Framework to Counter Infectious Disease Crises

Download the Report
Highlights from Asia Launch, March 13, 2016

Archived Video — Report Release Event, January 13, 2016


2016.1.06 PandemicThe Ebola crisis in West Africa was both a tragedy and a wakeup call, revealing dangerous deficiencies across global systems to prevent, prepare, and respond to infectious disease crises. To address these shortcomings and inform a more effective response in the future, the National Academy of Medicine convened the Commission on a Global Health Risk Framework for the Future (GHRF Commission)—an independent, international group of experts in finance, governance, R&D, health systems, and the social sciences.

The Commission’s report, which was published on January 13, highlights the essential role of pandemic preparedness in national security and economic stability—a critical but often under-examined dimension of the global conversation post-Ebola. Importantly, the report demonstrates that the impact of infectious disease crises goes far beyond human health alone—and that mitigation, likewise, requires the mobilization and long-term commitment of multiple sectors.




Report Release Event – January 13, 2016

Asia Launch of the Report-March 13, 2016

Evidence-Gathering Workshops

  • Commissioners

    The GHRF Commission is made up of 17 international experts in governance; finance; disease control; surveillance; workforce mobilization; humanitarian and pandemic response; health systems; public-private partnerships; social science; and research, development, acquisition, and distribution. Commissioners were screened for conflicts of interest to ensure their independence. See commissioner biographies >>

    Peter Sands, MPA (Chair)
    Former Group Chief Executive Officer
    Standard Chartered PLC
    Senior Fellow
    Mossavar-Rahmani Center for Business and Government, Harvard Kennedy School

    Oyewale Tomori, DVM, PhD (Vice Chair)
    Nigeria Academy of Sciences

    Ximena Aguilera, MD
    Director, Center of Epidemiology and Public Health Policies
    Universidad del Desarrollo, Chile

    Irene Akua Agyepong, DrPh, MBChB, FGCPS
    Greater Accra Regional Health Directorate
    Ghana Health Service

    Yvette Chesson Wureh, JD
    Establishment Coordinator
    Angie Brooks International Centre for Women’s Empowerment, Leadership Development, International Peace & Security
    C/O The University of Liberia

    Paul Farmer, MD, PhD
    Kolokotrones University Professor and Chair of the Department of Global Health and Social Medicine
    Harvard Medical School
    Cofounder of Partners in Health

    Maria Freire, PhD
    Foundation for the National Institutes of Health

    Julio Frenk, MD, MPH, PhD
    University of Miami

    Lawrence Gostin, JD
    University Professor of Global Health Law
    Georgetown University
    Faculty Director
    O’Neill Institute on National and Global Law

    Gabriel Leung, MD, MPH
    Li Ka Shing Faculty of Medicine
    University of Hong Kong

    Francis Omaswa, MBBCh, MMed, FRCS, FCS
    Executive Director
    African Center for Global Health and Social Transformation

    Melissa Parker, DPhil
    Reader in Medical Anthropology
    Department of Global Health and Development
    London School of Hygiene & Tropical Medicine

    Sujatha Rao, MA, MPA
    Former Secretary
    Ministry of Health and Family Welfare of India

    Daniel Ryan, MA
    Head of R&D – Life & Health and Big Data
    Swiss Re

    Jeanette Vega, MD, MPH, PhD
    Chilean National Health Fund

    Suwit Wibulpolprasert, MD
    Vice Chair
    International Health Policy Program Foundation
    Health Intervention and Technology Assessment
    Ministry of Public Health, Thailand

    Tadataka Yamada, MD
    Venture Partner
    Frazier Life Sciences

  • International Oversight Group

    The NAM formed an International Oversight Group (IOG), a global body of experts, to ensure the independence and objectivity of the Commission, and to protect integrity and maintain public confidence in the process.

    • Victor Dzau (Chair), President, National Academy of Medicine
    • Judith Rodin (Vice-Chair), President, Rockefeller Foundation
    • Fazle Hasan Abed, Founder of BRAC and Chairman of BRAC Bank Limited
    • Arnaud Bernaert, Senior Director, Head of Global Health and Healthcare Industries, World Economic Forum
    • Chris Elias, President of the Global Development Program, Bill & Melinda Gates Foundation
    • Jeremy Farrar, President, Wellcome Trust
    • Shigeru Omi, President, Japan Community Health Care Organization
    • Paul Polman, CEO, Unilever
    • Tan Chorh Chuan, President, National University of Singapore
    • Miriam Were, Chancellor, Moi University
    • Mirta Roses, Former Director-General, Pan American Health Organization
    • Shen Xiaoming, Professor of Pediatrics, Xin Hua Hospital and Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine
  • Evidence-Gathering Workshops

    As part of its workplan, the Commission received input from four Institute of Medicine workshops on the following topics:

    Governance for global health. The first workshop explored global, national, and local capabilities to facilitate the collective action of governmental, intergovernmental, corporate, and nonprofit sectors as they contribute to preparedness and response.

    Financing response to pandemic threats. The second workshop examined public- and private-sector roles in financing preparedness and response to epidemics. Topics included financing mechanisms for public health surveillance, workforce mobilization, and acquisition of medical commodities that can channel funds swiftly while minimizing transaction times and other expenses.

    Resilient health systems. The third workshop explored integrated surveillance and health information systems; workforce capacity; health system infrastructure; community, regional, and global partner engagement; and supply chain coordination and management.

    Research and development of medical products. The final workshop assessed current product development platforms; explore incentives and infrastructure for product development and conditions and needs for effective public-private partnerships; and addressed standards and approaches for regulatory harmonization and systems capacity.

    To develop its report, the commission considered evidence supplied by the workshops and lessons learned from the recent Ebola outbreak and other outbreaks of global impact, such as H1N1 influenza, Middle East Respiratory Syndrome (MERS), and Severe Acute Respiratory Syndrome (SARS). The commission deliberated and evaluated options to strengthen global, regional, national, and local systems to better prepare, detect, and respond to epidemic infectious diseases. Ultimately, the report will furnish conclusions and actionable recommendations to guide policy makers, international funders, civil society organizations, and the private sector.

  • Project Staff

    Ceci Mundaca-Shah, Project Director
    V. Ayano Ogawa, Associate Program Officer
    Patrick Kelley, Director, Board on Global Health


For more information, e-mail